University of Michigan receives grant to study pain management in opioid use disorder

Liq­uidia said in an SEC fil­ing Wednes­day that it will “ag­gres­sive­ly de­fend” against a po­ten­tial new patent cov­er­ing Unit­ed Ther­a­peu­tics’ tre­pros­tinil for the treat­ment of

Share this article The Phase I trial will enrol 10 patients at the Clatterbridge Cancer Centre in Liverpool, shown above, and is funded by the

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director